Trial intelligence / Profile preview

Uracil Topical Cream for Hand-Foot Syndrome Prevention

NCT01100463Phase 2Completed

Sponsor
Nanometics
Start
Apr 2010
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of uracil in palmar-plantar erythrodysesthesia (PPE), sponsored by Nanometics. Started Apr 2010; status: completed.

02

Drugs

uracil
03

Conditions

palmar-plantar erythrodysesthesia (PPE)

Beyond the preview

Go deeper on NCT01100463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01100463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call